Shares of Biogen skyrocketed roughly 40 percent Tuesday after the biotech company said it will seek approval for an Alzheimer's treatment after abandoning the drug earlier this year.
Freddie Joyner has the story.
Biogen resurrects Alzheimer's drug, stock soars
Credit: Rumble
Duration: 00:59s
0 shares
1 views